Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

This study has been terminated.
(The 001 trial did not show benefit versus placebo)
Information provided by:
XTL Biopharmaceuticals Identifier:
First received: January 9, 2008
Last updated: June 29, 2009
Last verified: June 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)